ALISE REICIN, PRES., GLOBAL CLINICAL DEV. at Celgene, holds 0.00 shares in Celgene (Ticker: CELG), holds ― shares in Q32 Bio (Ticker: QTTB), holds ― shares in Sana Biotechnology (Ticker: SANA).
ALISE REICIN latest transaction was an Uninformative Buy of ―.
What was ALISE REICIN's most profitable transaction?
ALISE REICIN’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is ALISE REICIN's role in Celgene?
ALISE REICIN's role in Celgene is PRES., GLOBAL CLINICAL DEV..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.